CDISC can be made up of 200 global agencies including leading Biotech and Pharmaceutical companies nearly, CROs, and academic institutions. Their mission is to develop and support global data standards that enable info exchange to boost medical study with a eyesight toward patient care and safety. To joining Prior, Chiltern has been pursuing CDISC standards with experience in reporting over 100 research using the SDTM and ADaM models. Right now as a member of CDISC, Chiltern will collaborate with global leaders and contribute toward the advancement and release of fresh standards.SOURCE BARRX Medical, Inc. Researchers from the University of Pennsylvania College of Medicine showed that the microtubule-stabilizing drug Paxceed helps appropriate the problems caused by clumped tau proteins in the nerve cells of mice. Our hope is that microtubule-stabilizing medications could be used to take care of Alzheimer’s and additional related diseases, says John Q. Trojanowski, MD, PhD, Director of the Institute on Ageing and Co-director of the Center for Neurodegenerative Disease Analysis and the Marian S. Ware Alzheimer Program at Penn. This research appears in the December 20 early online edition of the Proceedings of the National Academy of Sciences.